Determining the Pharmacodynamic Impact of Vaginal and IM Progestins on the Cervix
D
David Haas, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to identify biomarkers that change with progestin treatment.
Description
The purpose of this study is to identify biomarkers that change with progestin treatment.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Healthy
-
Age: Between 18 Years - 50 Years
-
Gender: All
Updated on
25 Apr 2024.
Study ID: 1305011354
